Literature DB >> 21474118

Reduction in lipopolysaccharide-induced apoptosis of fibroblasts obtained from a patient with gingival overgrowth during nifedipine-treatment.

Reiri Takeuchi1, Hiroko Matsumoto, Yoshiaki Akimoto, Akira Fujii.   

Abstract

OBJECTIVE: We have previously demonstrated that the mechanism of nifedipine (NIF)-induced gingival overgrowth is related to the observation that proliferation and cell cycle progression of gingival fibroblasts derived from NIF reactive patient (NIFr) are greater than those from NIF non-reactive patient (NIFn). Gingival overgrowth has also been reported to be a result of inhibited apoptosis of gingival fibroblasts. Apoptosis in fibroblasts is induced by lipopolysaccharide (LPS). Thus, we focused upon evaluating whether there is a difference in LPS-induced apoptosis between NIFn and NIFr.
METHODS: Both NIFn and NIFr were arrested in DMEM containing 0.5% FBS, stimulated by LPS, and assayed for apoptosis, cell cycle analysis, Western blotting, and caspase activity.
RESULTS: Compared to NIFn, the number of apoptotic cells was significantly decreased and the percentage of cells in S and G(2)/M phase was significantly increased in NIFr. The levels of Bax and cytochrome c proteins in NIFr were not up-regulated by LPS compared with NIFn. Both NIFn and NIFr displayed the following changes in protein expression: increased Bad, decreased Bcl-xL, and unchanged Bcl-2 and p53. Caspase-3 and -9 activities were significantly increased by LPS in NIFn but were unchanged in NIFr. Caspase-2 activity remained constant whilst caspase-8 activity significantly increased upon LPS treatment in both NIFn and NIFr.
CONCLUSION: Bad, Bax, cytochrome c, p53, and caspases-2, -3, -8, and -9 are pro-apoptotic proteins. Bcl-2 and Bcl-xL are anti-apoptotic proteins. Thus, the mechanism of NIF-induced gingival overgrowth might be related to decreased apoptosis in NIFr through a reduction of Bax, cytochrome c, and caspase-3 and -9.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21474118     DOI: 10.1016/j.archoralbio.2011.03.006

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  4 in total

1.  Possible pharmacotherapy for nifedipine-induced gingival overgrowth: 18α-glycyrrhetinic acid inhibits human gingival fibroblast growth.

Authors:  R Takeuchi; K Hiratsuka; K Arikawa; M Ono; M Komiya; Y Akimoto; A Fujii; H Matsumoto
Journal:  Br J Pharmacol       Date:  2016-02-03       Impact factor: 8.739

2.  Modulation of inflammatory response of wounds by antimicrobial photodynamic therapy.

Authors:  Khageswar Sahu; Mrinalini Sharma; Pradeep Kumar Gupta
Journal:  Laser Ther       Date:  2015-10-02

3.  Lipopolysaccharide induces lung fibroblast proliferation through Toll-like receptor 4 signaling and the phosphoinositide3-kinase-Akt pathway.

Authors:  Zhengyu He; Yuan Gao; Yuxiao Deng; Wen Li; Yongming Chen; Shunpeng Xing; Xianyuan Zhao; Jia Ding; Xiangrui Wang
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

4.  Epigenetic regulation of Thy-1 gene expression by histone modification is involved in lipopolysaccharide-induced lung fibroblast proliferation.

Authors:  Zhengyu He; Xiangrui Wang; Yuxiao Deng; Wen Li; Yongming Chen; Shunpeng Xing; Xianyuan Zhao; Jia Ding; Yuan Gao
Journal:  J Cell Mol Med       Date:  2013-01-11       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.